Settlement resolves FTC lawsuit alleging that Express Scripts' conduct resulted in artificially inflated insulin drug prices
The Federal Trade Commission secured a landmark settlement with one of the nation's largest pharmacy benefit managers ("PBMs"), Express Scripts, Inc., and its affiliated entities (collectively "ESI").View Press Release
View Press Release: https://www.ftc.gov/news-events/news/press-releases/2026/02/ftc-secures-landmark-settlement-express-scripts-lower-drug-costs-american-patients
(END) Dow Jones Newswires
February 11, 2026 11:40 ET (16:40 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.